Abstract
Familial heterozygous hypercholesterolaemia is the most relevant lipid disorder, which diminishes the life expectancy of affected patients by 15–30 years. Diagnosis in childhood can be easily established by LDL-cholesterol screening – and in case of elevated levels – genetic testing. Early therapy improves prognosis significantly. The Vroni study analyses the feasibility and efficiency of a population-wide screening for FH in order to improve the treatment of affected families.
| Translated title of the contribution | Familial hypercholesterolaemia – target of the Vroni study |
|---|---|
| Original language | German |
| Pages (from-to) | 619-626 |
| Number of pages | 8 |
| Journal | Internistische Praxis |
| Volume | 64 |
| Issue number | 4 |
| State | Published - 2022 |
